Status:
ACTIVE_NOT_RECRUITING
Liquid Biopsy Collection Study
Lead Sponsor:
University of Central Florida
Conditions:
Chaperonin-Containing TCP-1
Circulating Tumor Cells
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to develop a liquid biopsy approach for detection of circulating tumor cells (CTC) that could be used in place of the more invasive and potentially risky methods of tissue...
Eligibility Criteria
Inclusion
- Male or female
- Age greater than or equal to 18 and less than or equal to 80 years.
Exclusion
- Adults unable to give informed consent
- Individuals who are not yet adults (infants, children, teenagers; under the age of 18)
- Individuals who weigh less than 110 lbs (as standard clinically advised to not give blood)
- Pregnant women (due to hormonal changes in blood)
- Prisoners
- Persons reporting a current microbial (bacterial, viral, or fungal) infections
- Persons reporting that they are current taking antibiotic medications
- Persons with body temperatures above 99oF (indicating a fever)
Key Trial Info
Start Date :
October 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06068348
Start Date
October 7 2021
End Date
October 1 2025
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Central Florida
Orlando, Florida, United States, 32816